Qatar Business Standard

  • Home
  • Contact Us
Friday, July 4, 2025
You are here: Home » Archives for health

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an

on June 24, 2025 · Leave a Comment

Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) — Read more »

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine

on June 24, 2025 · Leave a Comment

DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) — Read more »

Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA

on June 24, 2025 · Leave a Comment

DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — A Read more »

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

on June 24, 2025 · Leave a Comment

DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Read more »

Noted Vaccine Researcher and Leader Kate O’Brien Awarded Sabin’s Gold Medal; Physician Livancliff Mbianke of Cameroon Receives Rising Star Award

on May 14, 2025

WASHINGTON, May 13, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute today awarded the Albert B. Sabin Gold Medal to pediatrician Katherine O’Brien, MD, MPH, for her research on the pneumococcal vaccine and [...] Read more »

DEBRICHEM® Wins 2025 IIWCG Achievement Award for Innovation in Wound Care

on April 30, 2025

AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) — DEBRICHEM®, the flagship product of DEBx Medical has been awarded the IIWCG Achievement Award 2025 for Innovation in Wound Care at the [...] Read more »

DEBRICHEM® se voit décerner le prix 2025 IIWCG Achievement Award récompensant l’innovation dans le domaine du soin des plaies

on April 30, 2025

AMSTERDAM, 30 avr. 2025 (GLOBE NEWSWIRE) — DEBRICHEM®, le produit phare de DEBx Medical, a obtenu le prix IIWCG Achievement Award 2025 récompensant l’innovation dans le [...] Read more »

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

on April 3, 2025

MNV–201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria

Read more »

Society for Clinical Research Sites (SCRS) und Fortrea gehen eine Partnerschaft zur Förderung der Zusammenarbeit in der klinischen Forschung ein

on February 20, 2025

DURHAM, North Carolina, Feb. 20, 2025 (GLOBE NEWSWIRE) — Die Society for Clinical Research Sites (SCRS) und Fortrea (Nasdaq: FTRE), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization, [...] Read more »

La Society for Clinical Research Sites (SCRS) et Fortrea s’associent pour promouvoir la collaboration dans le domaine de la recherche clinique

on February 20, 2025

DURHAM, N.C., 20 févr. 2025 (GLOBE NEWSWIRE) — La Society for Clinical Research Sites (SCRS) et Fortrea (Nasdaq : FTRE), l’une des principales organisations de recherche contractuelle (ORC) à [...] Read more »

Society for Clinical Research Sites (SCRS) e Fortrea Fazem Parceria para Promover a Colaboração na Pesquisa Clínica

on February 20, 2025

DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) — A Society for Clinical Research Sites (SCRS) e a Fortrea (Nasdaq: FTRE), uma organização líder global de pesquisa por contrato (CRO), tem o prazer de anunciar o [...] Read more »

Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research

on February 20, 2025

DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) — The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), are pleased to announce Fortrea’s [...] Read more »

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

on February 19, 2025

JERUSALEM , Feb. 19, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies in tablet [...] Read more »

Workplace Options stellt umfassendes und engagiertes Wiedereingliederungsprogramm für Krebsüberlebende vor

on January 24, 2025

RALEIGH, North Carolina, Jan. 24, 2025 (GLOBE NEWSWIRE) — Die Rückkehr an den Arbeitsplatz nach einer Krebsdiagnose ist mit vielen großen Herausforderungen verbunden – körperliche Erschöpfung, emotionale [...] Read more »

Workplace Options lance un programme complet et compatissant de retour au travail pour les personnes ayant survécu à un cancer

on January 24, 2025

RALEIGH, Caroline du Nord, 24 janv. 2025 (GLOBE NEWSWIRE) — Le retour au travail après un diagnostic de cancer est un parcours semé d’embûches qui mêle fatigue physique, obstacles émotionnels et [...] Read more »

Next Page »
k-Detail-of-colorful-group-of-vi-26488397-2

Automotive

Telecom

Telecom

Chemicals

Chemicals

Government

Government

RSS Unknown Feed

Arabic

  • POL: All Chinese ports (ShenZhen/ShangHai...)

  • POL: All Chinese ports (ShenZhen/ShangHai...)

  • POL: All Chinese ports (ShenZhen/ShangHai...)

  • Acapture

  • شركة أرو إليكترونكس تعتزم تقديم أدوات نت سكاوت المتنقلة للتحليل وتشخيص الأعطال وإصلاحها للمساعدة في تحقيق أقصى حد لأداء شبكة الواي فاي (WiFi) في الشرق الأوسط


<< المزيد

  Qatari Rial Exchange Rate

 

Calendar

July 2025
M T W T F S S
« Jun    
 123456
78910111213
14151617181920
21222324252627
28293031  

Admin Login

Copyright © 2025 Qatar Business Standard